Inventor
GRECO MICHAEL N
US30 patents
⚠️ This page may combine multiple inventors who share the name “GRECO MICHAEL N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GRECO MICHAEL N
11 patentsUS8207338B2Jun 26, 2012
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations61
US8497373B2Jul 30, 2013
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations58
US8609888B2Dec 17, 2013
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8461195B2Jun 11, 2013
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8304430B2Nov 6, 2012
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8247599B2Aug 21, 2012
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8212039B2Jul 3, 2012
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8198440B2Jun 12, 2012
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8178673B2May 15, 2012
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations50
US8394804B2Mar 12, 2013
Phosphonic acid compounds as inhibitors of serine proteases
GRECO MICHAEL N0 citations47
US8476302B2Jul 2, 2013
α-ketoamide derivatives useful endothelial lipase inhibitors
GRECO MICHAEL N0 citations38
JANSSEN PHARMACEUTICA NV
10 patentsUS5491161AFeb 13, 1996
Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
JANSSEN PHARMACEUTICA NV24 citations92
US5066656ANov 19, 1991
Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
JANSSEN PHARMACEUTICA NV18 citations73
US7459444B2Dec 2, 2008
Inhibitors of chymase
JANSSEN PHARMACEUTICA NV4 citations62
US5457102AOct 10, 1995
Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
JANSSEN PHARMACEUTICA NV3 citations62
US8703957B2Apr 22, 2014
Phosphonic acid compounds as inhibitors of serine proteases
JANSSEN PHARMACEUTICA NV0 citations61
US10118900B2Nov 6, 2018
Benzimidazole derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV1 citations51
US9815790B2Nov 14, 2017
Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV0 citations41
US9682940B2Jun 20, 2017
Indazole derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV0 citations41
US9732061B2Aug 15, 2017
Cinnoline derivatives useful as CB-1 receptor inverse agonists
JANSSEN PHARMACEUTICA NV0 citations37
US9682955B2Jun 20, 2017
Quinazoline derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV0 citations36
ORTHO MCNEIL PHARM INC
5 patentsUS7459461B2Dec 2, 2008
Phosphonic acid compounds as inhibitors of serine proteases
ORTHO MCNEIL PHARM INC17 citations89
US6538017B2Mar 25, 2003
Aminopyrrolidine sulfonamides as serine protease inhibitors
ORTHO MCNEIL PHARM INC9 citations73
US6765004B1Jul 20, 2004
Indoloazepines as vasopressin receptor antagonists
ORTHO MCNEIL PHARM INC6 citations62
US6890939B2May 10, 2005
Aminopyrrolidine sulfonamides as serine protease inhibitors
ORTHO MCNEIL PHARM INC0 citations51
US6630505B2Oct 7, 2003
Aminopyrrolidine sulfonamides as serine protease inhibitors
ORTHO MCNEIL PHARM INC0 citations51